Pesquisas alternativas:
company paises » company raises (Expandir a Pesquisa), compagnie paises (Expandir a Pesquisa), company promises (Expandir a Pesquisa)
complex cause » complex causes (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
compared can » compared case (Expandir a Pesquisa), compared a (Expandir a Pesquisa), compared law (Expandir a Pesquisa)
ml compared » gel compared (Expandir a Pesquisa), oil compared (Expandir a Pesquisa), model compared (Expandir a Pesquisa)
oil company » oil companies (Expandir a Pesquisa)
gl complex » l complex (Expandir a Pesquisa), msl complex (Expandir a Pesquisa)
paises nas » paises mas (Expandir a Pesquisa), paises las (Expandir a Pesquisa), paises nao (Expandir a Pesquisa)
can newly » a newly (Expandir a Pesquisa), can new (Expandir a Pesquisa), men newly (Expandir a Pesquisa)
cause new » causes new (Expandir a Pesquisa), use new (Expandir a Pesquisa), cause non (Expandir a Pesquisa)
5 gl » 5 yl (Expandir a Pesquisa), _ gl (Expandir a Pesquisa), 5 il (Expandir a Pesquisa)
company paises » company raises (Expandir a Pesquisa), compagnie paises (Expandir a Pesquisa), company promises (Expandir a Pesquisa)
complex cause » complex causes (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
compared can » compared case (Expandir a Pesquisa), compared a (Expandir a Pesquisa), compared law (Expandir a Pesquisa)
ml compared » gel compared (Expandir a Pesquisa), oil compared (Expandir a Pesquisa), model compared (Expandir a Pesquisa)
oil company » oil companies (Expandir a Pesquisa)
gl complex » l complex (Expandir a Pesquisa), msl complex (Expandir a Pesquisa)
paises nas » paises mas (Expandir a Pesquisa), paises las (Expandir a Pesquisa), paises nao (Expandir a Pesquisa)
can newly » a newly (Expandir a Pesquisa), can new (Expandir a Pesquisa), men newly (Expandir a Pesquisa)
cause new » causes new (Expandir a Pesquisa), use new (Expandir a Pesquisa), cause non (Expandir a Pesquisa)
5 gl » 5 yl (Expandir a Pesquisa), _ gl (Expandir a Pesquisa), 5 il (Expandir a Pesquisa)
1
Por Panahifar, Arash, Swanston, Treena M., Pushie, M. Jake, Belev, George, Chapman, Dean, Weber, Lynn, Cooper, David M.L.
Publicado no Phys Med Biol (2016)
“...Bone is a dynamic tissue which exhibits complex patterns of growth as well as continuous internal...”Publicado no Phys Med Biol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Karabulut, Barış, Can-Karabulut, Deniz C., Güleç, Serkan, Doğan, Cem M.
Publicado no J Clin Exp Dent (2016)
“... extensively. However, there is little information available regarding the effects of ‘newly developed...”Publicado no J Clin Exp Dent (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Simas, Marcelo Marinho., Coelho, José Mário, Motta, Regis da Rocha, Universidade Federal do Rio de Janeiro.
Publicado em 2012
Assuntos:
“...Países do BRICS Teses...”Publicado em 2012
Obter o texto integral
Livro
4
“...-immunoglobulin antibodies in children with newly diagnosed type 1 diabetes mellitus, using as a target cow...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Bolduc, Stéphane, Lacombe, Louis, Naud, Alain, Grégoire, Mireille, Fradet, Yves, Tremblay, Roland R
Publicado em 2007
“... cutoff for urinary PSA at > 150 ng/mL, with a sensitivity of 92.5%. When comparing prostate cancer...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Artigo
6
Por Willems, Esther, Alkema, Wynand, Keizer-Garritsen, Jenneke, Suppers, Anouk, van der Flier, Michiel, Philipsen, Ria H.L.A., van den Heuvel, Lambert P., Volokhina, Elena, van der Molen, Renate G., Herberg, Jethro A., Levin, Michael, Wright, Victoria J., Ahout, Inge M.L., Ferwerda, Gerben, Emonts, Marieke, Boeddha, Navin P., Rivero-Calle, Irene, Torres, Federico Martinon, Wessels, Hans J.C.T., de Groot, Ronald, van Gool, Alain J., Gloerich, Jolein, de Jonge, Marien I.
Publicado no EBioMedicine (2019)
“..., classical pathway components C1QA, C1QB, C1QC, C1R, and terminal pathway components C5, C8, C9, as compared...”Publicado no EBioMedicine (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Jaiswal, Sanjay, Patil, Veerendra, Satish Kumar, K. S., Ratnakar, P., Rairam, Surabhi, Tripathi, Supratim
Publicado no J Conserv Dent (2018)
“... results than EDTA. CONCLUSION: Fumaric acid can be tried as a new irrigating agent for smear layer removal...”Publicado no J Conserv Dent (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Slogotskaya, Liudmila, Bogorodskaya, Elena, Ivanova, Diana, Sevostyanova, Tatiana
Publicado no PLoS One (2018)
“... tuberculosis-specific recombinant proteins CFP10-ESAT6, for skin testing (0.2 μg/0.1 ml). STUDY PURPOSE...”Publicado no PLoS One (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Manabe, Yoshihiko, Shibamoto, Yuta, Sugie, Chikao, Hayashi, Akihiro, Murai, Taro, Yanagi, Takeshi
Publicado no Technol Cancer Res Treat (2015)
“.... The mean V5 Gy of the whole body was 1,826, 2,143, 1,983, and 2,939 ml, respectively (p < 0.0001...”Publicado no Technol Cancer Res Treat (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... rate of less than 15ml/sec into three groups by their defined daily dose (DDD) of 5ARI used...”
Obter o texto integral
Obter o texto integral
Artigo
11
Por Lin, Wenhsu, Lee, Shangsen, Wu, Jengyuan, Kuo, Yuhung, Hsieh, Tengfu
Publicado no PLoS One (2017)
“... of less than 15 ml/sec in 10 years of follow-up. But long-term 5ARI used can postpone AUR and TURP...”Publicado no PLoS One (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Li, Peihua, Ye, Huiming, Liu, Jiangwu, Jin, Hongwei, Lin, Yongzhi, Yan, Shuidi, Yu, Yang, Gao, Lei, Xu, Feihai, Zhang, Zhongying
Publicado no J Clin Lab Anal (2017)
“.../mL. The reportable range was 0.5‐2400 U/mL. Recovery ratio was 100.0%‐104.8%. Coefficient...”Publicado no J Clin Lab Anal (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... proteases from five newly isolated and identified alkaliphiles from Lonar soda lake, India. The data...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Kazeem, Muinat Olanike, Shah, Umi Kalsom Md, Baharuddin, Azhari Samsu, AbdulRahman, Nor’ Aini
Publicado no Appl Biochem Biotechnol (2017)
“... CMCase (3.7- and 1.4-fold) and FPase (2.5- and 11.5-fold) compared to the untreated BAG and pretreated RH...”Publicado no Appl Biochem Biotechnol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Jung, Arne, Petersen, Henning, Teske, Lydia, Rautenschlein, Silke
Publicado no BMC Microbiol (2017)
“..., indicating that cloacal swabs can be used to examine intestinal colonization of broilers with EC. The new...”Publicado no BMC Microbiol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Lignocellulosic saccharification by a newly isolated bacterium, Ruminiclostridium thermocellum M3...
Por Sheng, Tao, Zhao, Lei, Gao, Ling-Fang, Liu, Wen-Zong, Cui, Min-Hua, Guo, Ze-Chong, Ma, Xiao-Dan, Ho, Shih-Hsin, Wang, Ai-Jie
Publicado no Biotechnol Biofuels (2016)
“... yield of 481.5 ± 16.0 mg/g Avicel, and a cellular β-glucosidase activity of up to 0.38 U/mL, which...”Publicado no Biotechnol Biofuels (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Ceylan, Cavit, Gazel, Eymen, Keleş, İbrahim, Doluoğlu, Ömer, Yığman, Metin
Publicado no Curr Urol (2016)
“... (f/t) prostate specific antigen (PSA) in patients newly diagnosed with prostate carcinoma. MATERIALS...”Publicado no Curr Urol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Ohseong Kwon, Tae Jin Kim, In Jae Lee, Seok-Soo Byun, Sang Eun Lee, Sung Kyu Hong
Publicado em 2014-01-01
“... patients in group A and B, we compared risk of unfavorable disease (pathologic GS ≥ 4+3 and/or pathologic...”Publicado em 2014-01-01
Obter o texto integral
Artigo
19
Por Kwon, Ohseong, Kim, Tae Jin, Lee, In Jae, Byun, Seok-Soo, Lee, Sang Eun, Hong, Sung Kyu
Publicado em 2014
“... as expanded group incorporating all patients in group A and B, we compared risk of unfavorable disease...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“...-consuming, requires trained staff and well-maintained equipments. The newly developed, rapid diagnostic...”
Obter o texto integral
Obter o texto integral
Artigo